These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hypouricemic effect of allopurinol and the novel xanthine oxidase inhibitor TEI-6720 in chimpanzees. Komoriya K, Osada Y, Hasegawa M, Horiuchi H, Kondo S, Couch RC, Griffin TB. Eur J Pharmacol; 1993 Dec 21; 250(3):455-60. PubMed ID: 8112406 [Abstract] [Full Text] [Related]
3. A comparative study on the hypouricemic activity and potency in renal xanthine calculus formation of two xanthine oxidase/xanthine dehydrogenase inhibitors: TEI-6720 and allopurinol in rats. Horiuchi H, Ota M, Kobayashi M, Kaneko H, Kasahara Y, Nishimura S, Kondo S, Komoriya K. Res Commun Mol Pathol Pharmacol; 1999 Dec 21; 104(3):307-19. PubMed ID: 10741381 [Abstract] [Full Text] [Related]
4. Aesculin possesses potent hypouricemic action in rodents but is devoid of xanthine oxidase/dehydrogenase inhibitory activity. Kong L, Zhou J, Wen Y, Li J, Cheng CH. Planta Med; 2002 Feb 21; 68(2):175-8. PubMed ID: 11859475 [Abstract] [Full Text] [Related]
5. Synthesis and structure-activity relationships of 1-phenylpyrazoles as xanthine oxidase inhibitors. Ishibuchi S, Morimoto H, Oe T, Ikebe T, Inoue H, Fukunari A, Kamezawa M, Yamada I, Naka Y. Bioorg Med Chem Lett; 2001 Apr 09; 11(7):879-82. PubMed ID: 11294382 [Abstract] [Full Text] [Related]
6. Febuxostat: a selective xanthine-oxidase/xanthine-dehydrogenase inhibitor for the management of hyperuricemia in adults with gout. Ernst ME, Fravel MA. Clin Ther; 2009 Nov 09; 31(11):2503-18. PubMed ID: 20109996 [Abstract] [Full Text] [Related]
9. Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase. Takano Y, Hase-Aoki K, Horiuchi H, Zhao L, Kasahara Y, Kondo S, Becker MA. Life Sci; 2005 Mar 04; 76(16):1835-47. PubMed ID: 15698861 [Abstract] [Full Text] [Related]
10. Effects of Biota orientalis extract and its flavonoid constituents, quercetin and rutin on serum uric acid levels in oxonate-induced mice and xanthine dehydrogenase and xanthine oxidase activities in mouse liver. Zhu JX, Wang Y, Kong LD, Yang C, Zhang X. J Ethnopharmacol; 2004 Jul 04; 93(1):133-40. PubMed ID: 15182918 [Abstract] [Full Text] [Related]
11. [Inhibitors of xanthine oxidoreductase]. Okamoto K. Nihon Rinsho; 2008 Apr 04; 66(4):748-53. PubMed ID: 18409526 [Abstract] [Full Text] [Related]
12. An allopurinol-controlled, randomized, double-dummy, double-blind, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study. Kamatani N, Fujimori S, Hada T, Hosoya T, Kohri K, Nakamura T, Ueda T, Yamamoto T, Yamanaka H, Matsuzawa Y. J Clin Rheumatol; 2011 Jun 04; 17(4 Suppl 2):S13-8. PubMed ID: 21654265 [Abstract] [Full Text] [Related]
13. A Chinese herbal medicine Ermiao wan reduces serum uric acid level and inhibits liver xanthine dehydrogenase and xanthine oxidase in mice. Kong LD, Yang C, Ge F, Wang HD, Guo YS. J Ethnopharmacol; 2004 Aug 04; 93(2-3):325-30. PubMed ID: 15234772 [Abstract] [Full Text] [Related]
14. An allopurinol-controlled, multicenter, randomized, open-label, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 2 exploratory clinical study. Kamatani N, Fujimori S, Hada T, Hosoya T, Kohri K, Nakamura T, Ueda T, Yamamoto T, Yamanaka H, Matsuzawa Y. J Clin Rheumatol; 2011 Jun 04; 17(4 Suppl 2):S44-9. PubMed ID: 21654269 [Abstract] [Full Text] [Related]
15. Y-700 [1-[3-Cyano-4-(2,2-dimethylpropoxy)phenyl]-1H-pyrazole-4-carboxylic acid]: a potent xanthine oxidoreductase inhibitor with hepatic excretion. Fukunari A, Okamoto K, Nishino T, Eger BT, Pai EF, Kamezawa M, Yamada I, Kato N. J Pharmacol Exp Ther; 2004 Nov 04; 311(2):519-28. PubMed ID: 15190124 [Abstract] [Full Text] [Related]
16. Longan seed extract reduces hyperuricemia via modulating urate transporters and suppressing xanthine oxidase activity. Hou CW, Lee YC, Hung HF, Fu HW, Jeng KC. Am J Chin Med; 2012 Nov 04; 40(5):979-91. PubMed ID: 22928829 [Abstract] [Full Text] [Related]
17. Effect of TEI-6720, a xanthine oxidase inhibitor, on the nucleoside transport in the lung cancer cell line A549. Yamamoto T, Moriwaki Y, Fujimura Y, Takahashi S, Tsutsumi Z, Tsutsui T, Higashino K, Hada T. Pharmacology; 2000 Jan 04; 60(1):34-40. PubMed ID: 10629441 [Abstract] [Full Text] [Related]
18. Hypouricemic effects of acacetin and 4,5-o-dicaffeoylquinic acid methyl ester on serum uric acid levels in potassium oxonate-pretreated rats. Nguyen MT, Awale S, Tezuka Y, Shi L, Zaidi SF, Ueda JY, Tran QL, Murakami Y, Matsumoto K, Kadota S. Biol Pharm Bull; 2005 Dec 04; 28(12):2231-4. PubMed ID: 16327155 [Abstract] [Full Text] [Related]
19. Effects of onion on serum uric acid levels and hepatic xanthine dehydrogenase/xanthine oxidase activities in hyperuricemic rats. Haidari F, Rashidi MR, Keshavarz SA, Mahboob SA, Eshraghian MR, Shahi MM. Pak J Biol Sci; 2008 Jul 15; 11(14):1779-84. PubMed ID: 18817216 [Abstract] [Full Text] [Related]
20. 3,4-Dihydroxy-5-nitrobenzaldehyde (DHNB) is a potent inhibitor of xanthine oxidase: a potential therapeutic agent for treatment of hyperuricemia and gout. Lü JM, Yao Q, Chen C. Biochem Pharmacol; 2013 Nov 01; 86(9):1328-37. PubMed ID: 23994369 [Abstract] [Full Text] [Related] Page: [Next] [New Search]